•  
  •  
 

Author Credentials

Emma I. Sherfinski Emily J. Vore, MD Mark H. Cooper, MD PhD Peimei He, MD

Author ORCID Identifier

https://orcid.org/0000-0002-6119-4000

Keywords

Chronic cavitary pulmonary aspergillosis (CCPA), pulmonary aspergillosis, chronic lung disease, medically refractory lung disease, surgical treatment of chronic lung disease

Disciplines

Bacterial Infections and Mycoses | Infectious Disease | Medicine and Health Sciences | Surgery

Abstract

Pulmonary Aspergillus infections are caused by the ubiquitous fungus mold when spores found in compost, dust, and plant material are inhaled. Manifestation of the disease is represented by a delicate balance between host and pathogen interactions, making Aspergillus infection more commonly observed in immunocompromised individuals. Chronic cavitary pulmonary aspergillosis (CCPA) is a subtype of pulmonary Aspergillosis associated with history of chronic or prior lung disease. Here we present the case of a non-immunocompromised 24-year-old male with a history of intermittent asthma with chronic pulmonary symptoms and finding of a lung mass on imaging. We describe the diagnostic challenge and surgical treatment of CCPA in medically refractory disease.

Share

COinS